RT @NeurologyToday: In a phase2 trial, 1 yr of aducanumab transfusions reduced Abeta plaque&slowed cognitive decline in mild #Alzheimers:ht…
In a phase2 trial, 1 yr of aducanumab transfusions reduced Abeta plaque&slowed cognitive decline in mild #Alzheimers:https://t.co/PsBYFEO8Ex
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @MarcGozlan: #Alzheimer : l'anticorps aducanumab réduit les plaques β-amyloïdes et induit un ralentissement du déclin cognitif https://t…
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/p4bKqvq9ES
Biogen predicts preventive drug for Alzheimer’s disease https://t.co/j7j5RVoJsE https://t.co/4oU8Mnp6M9 https://t.co/8kLVz5zrbU
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/oQ5DZqVS5Y
RT @BiblioCCGUNAM: #JuevesDeNature The antibody aducanumab reduces Aβ plaques in #Alzheimer’s disease https://t.co/l1a3Em2SBF
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
#antibody successfully reduces #amyloid levels https://t.co/Kz4rAat12M https://t.co/fYo1wss4r1
RT @NHFTNHSLibrary: #Alzheimers drug study gives tantalising results https://t.co/FzucaJ15Gu Original paper in @nature here https://t.co/jy…
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/5GNJLZtmHY @nature
RT @PubSnips: #Monoclonal #antibody #aducanumab enters #brain reduces #amyloid #β #plaques and slows #Alzheimer’s progression https://t.co/…
RT @yadindudai: Support for the amyloid hypothesis: Monoclonal Ab to amyloid-β reduces plaques & slows cognitive decline in mild AD https:/…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
#Monoclonal #antibody #aducanumab enters #brain reduces #amyloid #β #plaques and slows #Alzheimer’s progression https://t.co/Uv1ORl3qPk
Proof of principle. Small step need more research if it will be the ultimate therapeutic in Alzheimer's disease https://t.co/tYP8JuqRgt
Exciting publication. Progress in #Alzheimers disease treatment! https://t.co/mOSrcbdnxY https://t.co/Gc3Ll2CgW3
Support for the amyloid hypothesis: Monoclonal Ab to amyloid-β reduces plaques & slows cognitive decline in mild AD https://t.co/DZ6vCS4iK0
RT @Aiims1742: $BIIB Ph1b trial paper in @Nature #Aducanumab reduces #Alzheimers plaques https://t.co/lWFWrMjvET Promising/Early https://t…
$BIIB Ph1b trial paper in @Nature #Aducanumab reduces #Alzheimers plaques https://t.co/lWFWrMjvET Promising/Early https://t.co/gpMDDolNA9
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @hebusto: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/27iluDVUnJ https://t.co/p…
Aducanumab, monthly infusions for a year, showed a reduction in amyloid beta and slower cognitive decline vs PLA https://t.co/SeUP4Ck4xt
Make or break time for the Amyloid cascade hypothesis? ...Aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/7xTY967mWl
"Antibody reduces plaques in Alzheimer’s disease" A small study but a good start. https://t.co/UJnxtpyqI2
"Antibody reduces plaques in Alzheimer’s disease" A small study but a good start. https://t.co/yw6hOuU23F
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
https://t.co/pef8b2saGt No doubt aducanumab reduces Aβ plaques in brain but what about cognitive function? $BIIB
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
#JuevesDeNature The antibody aducanumab reduces Aβ plaques in #Alzheimer’s disease https://t.co/l1a3Em2SBF
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/qG1QrcoZm3
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
Unprecedented breakthrough could stop people from ever developing #Alzheimer's https://t.co/UGm9JJKtyB +https://t.co/UxSg8IrYYZ
RT @EricTopol: The Aβ amyloid-#Alzheimers story gets a shot in the arm https://t.co/8m5YQTurSn @NatureNews @biogen https://t.co/TGbLpntVow
RT @lemire: New hope for Alzheimer’s: “a slowing of clinical decline”. Reminder: we have *no* working therapy for Alzheimer’s. https://t.co…
New hope for Alzheimer’s: “a slowing of clinical decline”. Reminder: we have *no* working therapy for Alzheimer’s. https://t.co/eJp3jSLXgM
Chicos si todo sale bien podríamos zafar del Alzheimer https://t.co/rzhP6Y8xbU
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
Report in @nature of successful Phase 1b trial of anti-amyloid antibody stabilize cog decline in early Alzheimer's. https://t.co/juJIc2Eh6O
RT @PabloRichly: El aducanumab podría finalmente validar la teoría amiloide del Alzheimer https://t.co/nFTl53doj5
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
El aducanumab podría finalmente validar la teoría amiloide del Alzheimer https://t.co/nFTl53doj5
¿Primer tratamiento específico para el Alzheimer? Falta la fase 3 pero promete https://t.co/nFTl53doj5
RT @daniel_kraft: “This is the best news we’ve had in my 25 years of doing #Alzheimer’s research” Nature paper https://t.co/7hYios9nVC http…
Here is the URL link to the research paper (for hardcore scientists). Others stop w/ abstract. https://t.co/zfTPFWZBlx @RajeevSrinivasa
$BIIB Alzheimer discovery. First drug that reverses plaques found in Alz. brains: https://t.co/dnvtXqNPnG $IBB $BIB $BTK
Not muscle related but fascinating! The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/CH3uPOLdD8
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
New therapy success for Alzheimer's! https://t.co/gtb4AaoIkk
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
...the treatment of Alzheimer's Disease. Read the paper here https://t.co/uB69P9jTro (2/2)
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
Antibody reduces plaques in Alzheimer’s disease. https://t.co/xuYADxZKrZ
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @daniel_kraft: “This is the best news we’ve had in my 25 years of doing #Alzheimer’s research” Nature paper https://t.co/7hYios9nVC http…
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
https://t.co/QmxUQaSj7F A team at Biogen reports positive clinical results of Amyloid-beta clearance and cognitive improvements following …
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
Some cutting edge and promising research into treatment of Alzheimer's. https://t.co/MoJSfeqsBL
アデュカヌマブによるアミロイド除去療法はアルツハイマー治療に光明をもたらすか? The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/EcxCK4K5wf
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease https://t.co/e1iAP15aoU
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @h_okumura: アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
アルツハイマー病の新薬aducanumab Nature https://t.co/0sQuQTVkTG https://t.co/K2L3aLVnTm https://t.co/nj1T201juW
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @daniel_kraft: “This is the best news we’ve had in my 25 years of doing #Alzheimer’s research” Nature paper https://t.co/7hYios9nVC http…
Nature: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease https://t.co/GpcYZVUAgm?
RT @Brain_Foundry: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease | https://t.co/SuH0NNlpkH #Nature #Alzheimers #Society
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
Widely reported @nature paper on aducanumab & #Alzheimers | Authors say it's underpowered to detect clinical effect https://t.co/Ftw8BL8fyp
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @daniel_kraft: “This is the best news we’ve had in my 25 years of doing #Alzheimer’s research” Nature paper https://t.co/7hYios9nVC http…
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
RT @digitalsci: Intersting paper about a new drug that can reduce plaque in Alzeimers disease! https://t.co/LfaMrAmIRs https://t.co/FGsa778…
RT @nature: An antibody reduces Aβ deposits in the brains of patients with mild Alzheimer’s disease https://t.co/qaf5AzwNHn https://t.co/x5…
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…
Intersting paper about a new drug that can reduce plaque in Alzeimers disease! https://t.co/LfaMrAmIRs https://t.co/FGsa778mQP
RT @yuji_ikegaya: 【認知症の免疫療法 ついに成功か!?】アミロイドβ凝集体に対するヒトモノクローナル抗体を、毎月一回静脈注射すると、脳のアミロイドβが減少し、アルツハイマー型認知症の症状の進行を遅らせることができたそうです。今朝の『ネイチャー』誌より→http…